Dr. Daniel Waschke, PhDAssociate Regulatory Program Director at F. Hoffmann-La Roche Ltd.Speaker
Profile
Daniel is a Regulatory Program Director at Roche, bringing over 15 years of pharmaceutical industry experience dedicated exclusively to CMC regulatory affairs. He began his career at Bachem before joining Roche in 2017. While his background spans synthetic molecules across all stages of development, from early clinical trials through to commercialization, he has focused heavily on oligonucleotides and peptides since 2022. Beyond that, Daniel actively contributes to industry-wide harmonization as a member of EFPIA and EPOC workstreams. He holds a PhD in Organic Chemistry from the University of Hamburg
Agenda Sessions
Chairperson’s Remarks: Regulatory CMC Strategies for Oligonucleotides
, 08:00View Session

